GlobalData

In both groups, Nucala significantly lowered the rate of exacerbations requiring emergency department (ED) visits or…

GlobalData’s latest report reveals that the market for genomic therapies is demonstrating significant growth, with sales projected…

Market growth will primarily be driven by the increased uptake of long-acting injectable therapies, as well as the anticipated…

GlobalData reveals the pharma and healthcare industry reported 81 deals worth $9.6 billion and 85 venture capital deals worth $2…

GlobalData’s latest report reveals that the TCI space is entering a new growth phase, driven by clinical success and investor…

GlobalData’s latest report showcases an analysis of the GLP-1R agonists pipeline in multiple indications, highlighting the areas…

Significant advancements in treatments for dermatology disorders are anticipated, driven by innovations from both small to…

According to GlobalData’s report, oncology remains the leading therapeutic area in Q1 2025, with most of the deals targeting…

GlobalData survey uncovers stark regional differences in physician support for patient involvement in choosing between biologics…

GlobalData analyst highlights Leqselvi’s high-dose advantage and renewed market entry as key drivers for swift adoption, despite…